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Progressive myoclonic epilepsies (PMEs) comprise a group of rare disorders of different genetic 
aetiologies, leading to childhood-onset myoclonus, myoclonic seizures and subsequent neurological 
decline. One of the genetic causes for PME, a mutation in the gene coding for Golgi SNAP receptor 2 
(GOSR2), gives rise to a PME-subtype prevalent in Northern Europe and hence referred to as North Sea 
Progressive Myoclonic Epilepsy (NS-PME). Treatment for NS-PME, as for all PME subtypes, is 
symptomatic; the pathophysiology of NS-PME is currently unknown, precluding targeted therapy. 
Here, we investigated the pathophysiology of NS-PME. By means of chart review in combination with 
interviews with patients (n=14), we found heat to be an exacerbating factor for a majority of NS-PME 
patients (86%) . To substantiate these findings, we designed a  NS-PME Drosophila melanogaster model.  
Downregulation of the Drosophila GOSR2-orthologue Membrin leads to heat-induced seizure-like 
behaviour. Specific downregulation of GOSR2/Membrin in glia but not in neuronal cells resulted in a 
similar phenotype, which was progressive as the flies aged and was partially responsive to treatment 
with sodium barbital. Our data suggest a role for GOSR2 in glia in the pathophysiology of NS-PME. 




Progressive myoclonic epilepsies (PMEs) form a group of rare diseases of different genetic aetiologies 
(Kälviäinen, 2015; Malek et al., 2015). They are characterized clinically by a progressive neurological 
disorder starting in childhood with myoclonus and epilepsy (Kälviäinen, 2015; Malek et al., 2015). 
Mutations in the Golgi SNAP receptor 2 gene (GOSR2) cause a particular type of PME with a relatively 
high prevalence in countries bordering on the North Sea (Corbett et al., 2011; Boissé Lomax et al., 2013). 
Aside from its systematic classification as PME6, it is also known as North Sea progressive myoclonus 
epilepsy (NS-PME)(Boissé Lomax et al., 2013). Interestingly, nearly all patients known to date are 
homozygous for the same mutation (c.430G>T, Gly144Trp), leading to the amino acid change of an 
evolutionarily conserved residue of the GOSR2 protein (Corbett et al., 2011). The clinical phenotype of 
these patients consists of early-onset ataxia around the age of two years, followed by generalised 
cortical myoclonus around the age of six with seizures often starting in the second decade of life (Boissé 
Lomax et al., 2013; van Egmond et al., 2014). All these features are relentlessly progressive, causing 
patients to become wheelchair-bound in adolescence or adulthood and having a reduced life-
expectancy (Boissé Lomax et al., 2013). Despite the progressive neurological decline, no 
neurodegeneration is observed in imaging studies of affected patients or in the single post-mortem 
neuropathological study that was performed(Corbett et al., 2011). Also, cognitive function is relatively 
preserved in NS-PME (Boissé Lomax et al., 2013; van Egmond et al., 2014). Some have considered NS-
PME to be a subtype of progressive myoclonus ataxia (PMA), rather than a PME (van Egmond et al., 
2014). 
As in other types of PME/PMA, treatment is symptomatic and aimed at minimizing invalidating 
myoclonus and epilepsy using (combinations) of antiepileptic drugs (Kälviäinen, 2015; Malek et al., 
2015). Importantly, a large part of the antiepileptic armamentarium (e.g. phenytoin, carbamazepine, 
gabapentin) is known to potentially aggravate myoclonus and is therefore contraindicated in PME/PMA, 
limiting therapeutic options (Malek et al., 2015). Unfortunately, insight into the pathogenesis of NS-
PME/PMA is lacking, hampering the development of more targeted treatment strategies. 
The GOSR2 gene codes for a Qb-SNARE protein involved in traffic of proteins through the Golgi 
apparatus (Hong et al., 1997; Hay et al., 1998). The Gly144Trp amino acid change found in NS-PME/PMA 
patients most likely confers a loss of function, as this alteration in the yeast GOSR2 homologue bos1 
yielded a protein unable to complement the Δbos1 knockout strain, contrary to the wild type 
bos1(Corbett et al., 2011). In addition, the extent and rate of fusion of yeast liposomes with mutant 
bos1 was reduced compared to wild-type bos1 (Praschberger et al., 2017), supporting the notion that 
the mutation leads to a partial loss of function of the GOSR2 protein.  
Model organisms provide insight into pathophysiology of disease, particularly in the case of a known 
genetic defect. Over the last decades, the fruit fly (Drosophila melanogaster) has emerged as a versatile 
model organism for many conditions, including neurodegenerative diseases (Rana et al., 2010; Kinghorn 
et al., 2015) and epilepsy (Fergestad et al., 2006; Song and Tanouye, 2008). In a recently described 
Drosophila model of NS-PME/PMA, dendritic growth defects and discrete changes in larval 
neuromuscular junctions were reported (Praschberger et al., 2017). However, the exact 
pathophysiology of NS-PME/PMA remains unknown. 
Here, by collecting retrospective data and using semi-structured interviews aimed to identify factors 
that influence the symptoms of NS-PME/PMA patients, we found heat to worsen symptoms in a majority 
of patients. Because recall bias is a limiting factor in retrospective data collection, we aimed to back up 
the results with functional experiments in a model organism. Therefore, to further substantiate the 
significant clinical findings, we created a Drosophila model for NS-PME/PMA by knockdown of the 
GOSR2-orthologue Membrin, and observed seizure-like behaviour in adult flies, similar to that described 
for other fly-models of temperature-sensitive epilepsy. Intriguingly, this phenotype is recapitulated by 
glial, but not neuronal knockdown of Membrin, suggesting that the primary tissue in the CNS to 
dysfunction in NS-PME/PMA may be glia rather than neurons. We demonstrate that upon glial loss of 
Membrin, the phenotype is progressive with age and partially corrected by sodium barbital. The model 
will facilitate further research into the pathophysiology of NS-PME/PMA, with the opportunity of 
identifying potential targets for treatment.  
  
Materials and methods 
Patients and patient interviews 
From the medical records of 14 patients with NS-PME/PMA (age 4-44 years; male: female 10:4), we 
retrospectively collected factors influencing symptoms, in particular myoclonic jerks and seizures, both 
positively and negatively. In addition, we interviewed these 14 patients and/or their caregivers using a 
semi-structured interview with a focus on factors that influenced NS-PME/PMA symptoms. The 
interview was based upon factors identified in literature on NS-PME/PMA and from our retrospective 
data collection. All patients were genetically tested and found to have the same homozygous c.430G>T 
mutation in the GOSR2 gene. The effects of medication, diet, environmental conditions, internal factors 
(e.g. stress, anxiety) and intercurrent illness were systematically assessed. Duration of influencing 
factors were not assessed. All patients consented to participate; the study was performed in accordance 
with the regulations of the Human Research Ethics Committee and the University Medical Centre 
Groningen (UMCG) (Review board number UMCG M17.215724, Erasmus MC MEC-2018-1136) 
Drosophila maintenance, crosses and ageing. 
Drosophila flies were maintained and crosses were performed on Bloomington food at 25 °C. Stocks 
were obtained from the Bloomington Drosophila Stock Center: Actin-GAL4 (#4414), nSyb-GAL4 
(#51941), Elav-GAL4 (#8765), Repo-GAL4 (#7415) and UAS-GFP (#4775). The UAS-membrin-RNAi line 
(#44534) was obtained from the Vienna Drosophila Resource Center (VDRC).  
For the experiments, the eclosion and seizure-like phenotype of adult offspring was determined from 
crosses between a GAL4 driver line (nSyb, Elav, Repo or Actin) and UAS-membrin-RNAi (to downregulate 
Membrin in all or specific tissue), compared to the crossing of  a GAL4 driver with UAS-GFP (as a control). 
Downregulation of membrin by RNAi in all cells (when Actin-GAL4 was used as a ubiquitous driver) 
resulted in lethality in males, therefore only females were used to investigate the effect of 
downregulation of membrin in all cells using the Actin-GAL4 driver (Figure 1). With neuronal or glial 
expression (nSyb, Elav and Repo-GAL4) of membrin RNAi, eclosion of adult flies was not affected and 
both males and females were tested for their seizure phenotype and presented in separate graphs. 
For the seizure assays age-matched flies were used: Briefly, flies were collected on the day of eclosion 
(day 1) and aged for 3, 5 or 8 days (males and females separately), as indicated in figures and/or legends, 
after which the seizure assay was performed (see below). For additional administration of sodium-
barbital also see below. 
For the eclosion assay we started with 3 males and 5 females per vial, they were allowed to lay embryos 
for 3 days. For this experiments we used 4 biological replicates. The amount of progeny per genotype 
was determined. For this assay the Fisher’s exact test was used.   
Heat-induced seizure assay 
The heat-induced seizure paradigm was reported previously (Sun et al., 2012) The assay is depicted in 
Figure 2. Briefly, after ageing, flies were transferred to separate vials in groups of five to ten flies and 
left to acclimatise for at least 5 minutes. The vials were then (individually) immersed in a water bath of 
40 °C for a total of 120 seconds, during which each vial was inspected in 5 second intervals to score 
whether any of the flies showed seizure-like behaviour. As previously described, (Sun et al., 2012) 
seizure-like behaviour was defined as twitches of the legs, wing flapping and loss of standing position.  
When flies stopped their movement and were not in standing position, this was scored as paralysis.  
Paralysis of the flies was scored in a cumulative manner. Fly specifics such as genotype or treatment 
were blinded during the experiment. The data was processed as a survival function and statistically 
processed using the log-rank test. For the purpose of video recording, we employed a copper chamber 
heated to a surface temperature of 40°C: this chamber was not used for quantification purposes. 
 
Chemicals and administration 
Sodium barbital was obtained from Sigma-Aldrich. Barbital was tested at a conservative concentration 
of 0.5 mg/mL, which was previously shown to be the non-toxic threshold for fruit fly larvae, while 2 
mg/mL sodium barbital is toxic for adult flies (Howard et al., 1975). To test the short-term efficacy, 
barbital was administered 24 hours prior to the heat induced seizure assay by transferring the flies to a 
vial with Whatman filter soaked in 600 µL of apple juice with or without 0.5 mg/mL sodium barbital. To 
test the effect of barbital over an extended period, the flies were aged for 8 days on food supplemented 
with barbital in the final concentration of 0.5mg/mL or on a control solution. 
 
RNA isolation, quantitative real-time PCR, and primers.  
For membrin qPCR, 3-day-old adult flies were collected from a cross overexpressing UAS-membrin-RNAi 
under the control of Actin (Act-GAL4>UAS-membrin-RNAi) or overexpressing UAS-GFP as control (Act-
GAL4>UAS-GFP). The flies were briefly frozen in liquid nitrogen and afterwards the RNA was extracted 
using TRIzol (Invitrogen) and reverse-transcribed using M-MLV (Invitrogen) and oligo(dt) 12-18 
(Invitrogen). SYBR green (Bio-Rad) and Bio-Rad real-time PCR with specific primers were used for 
analyses of gene expression level. The expression levels were normalized for rp49 (housekeeping gene). 
The primer sequences used were as follows: membrin fp: 5′-TGGGTCTGTCCAATCACACG-3′, rp: 3′- 
CAAGGTGACCACCACTCCTC -5′ ; rp49 fp: 5'-CCGCTTCAAGGGACAGTATC-3', rp: 5'-
GACAATCTCCTTGCGCTTCT-3'. Primers were synthesised by Biolegio, Nijmegen. 
Western blot  
Protein levels were compared between samples from heads of 14 day old Act-GAL4>UAS-membrin-RNAi 
and Act-GAL4>UAS-GFP flies using Western Blot with anti-Membrin antibody (Abcam, ab115642, 
1:1000) as a primary antibody and HRP-linked anti-rabbit IgG as a secondary antibody. Anti-Tubulin was 
used to detect the loading control (Sigma, T5168, 1:5000). The images were obtained using a ChemiDoc 
MP (BioRad). 
Statistics 
Data was visualised and analysed using GraphPad Prism version 5. Statistical significance was performed 
using Fisher’s exact test (to compare groups of eclosing flies and to compare groups of surviving flies on 
sodium barbital), Mantel-Cox log-rank-test (for all graphs comparing seizure incidence between 
different genotypes/treatments in Fig 2-4) or a two-tailed unpaired Student’s t-test (to analyse the qPCR 
results in Fig 1). Data in Fig 1E shows mean ±SEM (n=3). p-values for all graphs: (* p≤0.05, ** p≤0.001, 
*** p≤0.0001). The number of flies used for the seizure assays is indicated behind the genotype in the 
graphs of Figures 2-4 and depicts the cumulative results of (at least) three independent experiments. 
  
Results 
Heat exacerbates symptoms in NS-PME/PMA patients 
In order to understand the pathophysiology of NS-PME, we interviewed 14 NS-PME/PMA patients with 
a specific emphasis on factors influencing their symptoms. The full results are displayed in Table 1. 
Interestingly, heat was reported to exacerbate symptoms in a majority of patients (Table 2). This not 
only included fever and intercurrent illness (11/14 patients, 79%), but also exogenous factors such as 
hot showers/baths (5/14 patients, 36%) and increased environmental temperature (7/14 patients, 
50%). In total, 12 patients (86%) reported at least one form of exogenous heat as exacerbating their NS-
PME/PMA symptoms. It should be noted that not all patients reported provocation of symptoms by heat 
and other, more well-known exacerbating factors such as (unexpected) noise, lights/flashes and stress 
were also frequently reported by patients (Table 3). Indeed, some patients reported avoidance of 
crowded places, as this also increased their myoclonic jerks. This is common for many other types of 
epilepsy and not all triggers (heat or non-heat related) are always shared by all patients. 
RNAi-mediated knockdown of Membrin causes a decrease of membrin mRNA and protein in vivo 
In order to explore the relevance of this clinical feature, especially the heat-induced seizures, a 
Drosophila melanogaster model for NS-PME/PMA was developed. For this, we used an RNAi-mediated 
knockdown approach and started by downregulating the Drosophila GOSR2 orthologue Membrin in all 
cells using the ubiquitous driver Actin-GAL4 (Act-GAL4). Downregulation of Membrin in all cells resulted 
in male lethality and a reduced survival rate to adulthood in female flies (Figure 1 A-D) compared to 
controls. Efficiency of the RNAi mediated knockdown was investigated in surviving females. qPCR and 
Western blot analysis confirmed that membrin mRNA and Membrin protein levels were reduced (Figure 
1E-F). Reduced viability upon ubiquitous downregulation of Membrin is consistent with previous 
studies(Praschberger et al., 2017).  
Ubiquitous knockdown of membrin is associated with sensitivity to heat-induced seizure-like behaviour 
Based on our clinical studies, we investigated whether the surviving female adult flies with ubiquitously 
reduced Membrin levels showed sensitivity to heat-induced seizure-like behaviour. To test this, we 
subjected age-matched control flies and flies with reduced Membrin levels to a waterbath of 40oC for 
up to 120 seconds, as previously described (Sun et al., 2012) (Figure 2). Seizure-like behaviour, 
characterised by twitching, wing flapping and loss of standing position, was not observed in control flies, 
in accordance with previous reports (Sun et al., 2012). However, in 5 day old Membrin-reduced flies, 
this seizure-like behaviour was observed in approximately 30% of flies in an accumulative manner, the 
longer the heat shock lasted, the more flies showed seizure-like behaviour (Figure 2E). These data are 
consistent with the clinical data and together demonstrate that impaired function of GOSR2/Membrin 
is associated with an occurrence of seizures provoked by heat.  
Heat-induced seizure sensitivity is recapitulated by glial, but not neuronal knockdown of Membrin and is 
progressive with age 
Both in humans and in Drosophila, the central nervous system (CNS) consists of neuronal cells and glial 
cells(Kremer et al., 2017). We proceeded to investigate in which cell type in the Drosophila central 
nervous system Membrin plays a role in preventing heat-induced seizure-like behaviour. To test this, 
we expressed the UAS-membrin-RNAi construct using either an exclusively neuronal or an exclusively 
glial driver, to induce the downregulation of membrin in each cell type separately. In contrast to 
ubiquitous downregulation of membrin using Act-GAL4 as a driver, specific downregulation of membrin 
in neuronal or glia cells did result in normal numbers of viable male and female offspring. Neuronal 
downregulation of membrin using either the Elav-GAL4 or the nSyb-GAL4 driver did not cause any 
seizure-like behaviour in response to heat (Figure 3A-D, females and males). In contrast, we did find an 
increase of heat-induced seizure-like behaviour using the glial driver Repo-GAL4. (Figure 3E-F, females 
and males,  and video 1). In concordance with the progressive nature of NS-PME/PMA, we observed 
that the incidence of seizure-like behaviour induced by heat increased as flies aged. Whereas no heat-
induced seizure-like behaviour was observed at 3 days of age, 20% of the female flies showed seizure-
like behaviour at 5 days and at the age of 8 days, approximately 40% of females seized within 120 
seconds in response to the heat stimulus (Figure 3E). Males showed a milder phenotype and  
approximately 30% of male flies showed heat-induced seizure-like behaviour within 120 seconds at 8 
days (Figure 3F). These data suggest that membrin expression is required in glial and not in neuronal 
cells to prevent heat-induced seizure-like behaviour during aging.  
Barbital suppresses heat-induced seizure-like behaviour  when membrin is downregulated in glia cells 
Seizure-like behaviour in Drosophila shares not only electrophysiological but also pharmacological 
features with human epilepsy, including responsivity to anticonvulsant drugs used in humans (Kuebler 
and Tanouye, 2002; Tan et al., 2004; Marley and Baines, 2011). In order to further investigate the 
seizure-like behaviour, we treated Membrin-downregulated flies with barbital, a GABA-agonist known 
to potently suppress seizures in humans.  
To exclude that barbital itself could have a detrimental effect on the ageing flies, we first assessed the 
survival of adult flies ageing for 8 days on regular food or food containing 0.5 mg/mL sodium barbital. 
The flies tested were control flies and flies with glial downregulation of membrin (Repo>membrin-RNAi). 
In the control flies we detected no difference between ageing on food with or without sodium barbital 
(75.7% for females and 92.5% for males without sodium barbital versus 71.4% for females and 92.5 % 
for males with sodium barbital), whereas female flies with glial-membrin knockdown showed an 
increased survival from 72.9% without sodium barbital to 83.6% with sodium barbital (p=0.042) and 
males an increased survival from 88.8% to 100% (p=0.003). These data showed that sodium barbital at 
this concentration does not harm the survival of adult flies for 8 days and improves slightly the survival 
of flies with glial membrin knockdown. 
Finally we tested the effect of sodium barbital administered via  the food 8 days prior to heat treatment 
on seizure-like behaviour of glial membrin knockdown flies.  Sodium barbital addition to the food 
resulted in a significant suppression of seizure-like behaviour in these flies (Figure 4A). This effect was 
also observed in flies that were treated with barbital only 24 hours prior to exposure to heat (Figure 4B). 
This indicates that the seizure-like behaviour observed in flies shares not only phenomenological, but 
also pharmacological properties with human epilepsy and opens up avenues to investigate more 
targeted therapies for patients with NS-PME/PMA. 
  
Discussion 
Here, we report on a translational study in North Sea Progressive Myoclonus Epilepsy. By chart review 
and interviewing 14 NS-PME/PMA patients, we found heat to be an exacerbating factor of symptoms in 
a majority of them. This effect is not limited to fever, a condition in which there is not only elevated 
body temperature but also increased immunological activity and stress which could potentially 
aggravate the symptoms; instead, also exogenously applied heat, in the absence of fever, such as 
showering, hot baths and increased environmental temperature provokes NS-PME/PMA symptoms. 
Concrete examples of the latter factor include indoor temperature or the temperature inside a car, 
information that is useful for the counselling of NS-PME/PMA patients. Heat-sensitive epilepsy is 
observed in febrile seizure syndromes as well as in Dravet syndrome, a syndrome associated with 
mutations in sodium channel SCN1A (Sun et al., 2012). Interestingly, it has been reported that a novel 
type of PME/PMA associated with neuronal potassium channel KCNC1 features the opposite effect, with 
improvement of symptoms during fever (Oliver et al., 2017). These observations suggest the presence 
of various distinct underlying epileptogenic mechanisms in this group of disorders, while simultaneously 
underlining the influence of temperature on channelopathies. 
Because recall bias is a limiting factor in retrospective data collection as performed in our initial study 
using clinical data, we further substantiated our findings and investigated heat-provoked symptoms in 
a Drosophila model, where we employed cell-specific RNAi-mediated downregulation to demonstrate 
that glial, but not neuronal loss of GOSR2-orthologue Membrin resulted in a progressive heat-sensitive 
seizure-like phenotype amenable to treatment with barbital. Another particular feature of this model is 
the progressive nature of the seizure sensitivity: this is not only reflected by stronger seizure-like 
behaviour induction by heat in older flies, but also in the observation that routine handling of flies 
provided sufficient mechanical stimulation to induce seizure-like behaviour as the flies age (data not 
shown). This is reminiscent of the progressive nature of NS-PME/PMA. In the current study we did not 
study additional behaviours potentially affected by loss of Membrin, such as  climbing, flight and 
learning and memory nor did we perform electrophysiology. It would be highly interesting to use our 
presented Drosophila model for these type of studies as well. 
Our observations show that ubiquitous downregulation of Membrin in male flies induces lethality and 
in female flies reduced viability. In contrast, specific downregulation of membrin in glia induces a 
stronger heat-induced seizing phenotype in females compared to males. Currently we do not have an 
explanation for these gender differences, however, differences in phenotype associated with gender 
are observed in other fly models as well (Brumby et al., 2011). 
Our findings that loss of Membrin specifically in glia but not specifically in neurons leads to seizure-like 
behaviour in adult flies elaborates further on earlier findings in Drosophila (Praschberger et al., 2017; 
Jepson et al., 2019), where changes in neuronal architecture, synaptic composition and 
electrophysiological seizure sensitivity at the larval neuromuscular junction were observed upon 
ubiquitous Membrin loss of function. Our study dissects the primarily neuronal from the primarily glial 
component of the phenotype caused by loss of Membrin. Our data certainly do not rule out a function 
for Membrin in neuronal cells, but they merely suggest that a function for Membrin in glia cells cannot 
be ignored. It is even possible that the neuronal phenotypes mentioned earlier (Praschberger et al., 
2017) may be secondary to glial loss of Membrin function. 
Glia emerge as important contributors to the pathophysiology of some types of epilepsy, due to the 
control they exert over the neuronal microenvironment. Derailment of this function leads to 
disequilibrium of ions and/or neurotransmitters, and as such may promote epilepsy (Robel and 
Sontheimer, 2016). Whether these mechanisms underlie the neurological features of NS-PME/PMA 
remains to be investigated, in Drosophila as well as in other models. The Drosophila model reported 
here may be useful as a platform to identify pathophysiological intermediates in NS-PME/PMA: these 
may include the glial partners of Membrin, as well as the crucial glia-neuron interaction involved in the 
seizure model. In addition, the model may aid the discovery of potential novel therapeutics that may 
benefit NS-PME/PMA patients.  
In conclusion, we have found heat to be an important negative influence on the symptoms of NS-
PME/PMA patients. Ubiquitous as well as glia-specific knockdown of GOSR2 orthologue Membrin in 
Drosophila gives rise to heat-induced seizure-like behaviour, recapitulating NS-PME/PMA and raising 
the possibility that the primary defect induced by loss-of-function mutations in GOSR2 is located in glia.  
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Figure 1: Ubiquitous knockdown of Drosophila membrin causes a decrease in eclosing adults and seizure-
like behaviour in (female) flies  
(A-D) Crossing scheme to obtain control flies (CyO>UAS-GFP; Act-GAL4>UAS-GFP; CyO>UAS-membrin-
RNAi) and flies in which Membrin is downregulated (Act-GAL4>UAS-membrin-RNAi) using the GAL4-UAS 
binary system. The results of the actual cross are depicted in (C-D): Control flies eclose in expected ratios 
according to Mendelian inheritance, Act-GAL4>UAS-membrin-RNAi males are lethal and Act-GAL4>UAS-
membrin-RNAi females eclose with reduced numbers. Groups were compared using Fisher’s exact test. 
(E) mRNA expression levels of Drosophila membrin, normalized with housekeeping gene rp49 expression 
levels in 3 day old adult females, ubiquitously expressing UAS-membrin-RNAi (Act-GAL4>UAS-membrin-
RNAi), to downregulate membrin in all cells. Act-GAL4>UAS-GFP females were used as age-matched 
controls. Data shows mean ± SEM (n=3) and two-tailed unpaired Student’s t-test was used (*p ≤ 0.05). 
(F) Western blot depicting Drosophila Membrin protein levels in Act-GAL4>UAS-membrin-RNAi 
(membrin downregulated) females and Act-GAL4>UAS-GFP females as controls. The Western was run 
on material from heads of 14 day old females. α-Tubulin was used as loading control.  
 
Figure 2: Schematic representation of heat-induced seizure assay. 
 
(A) Control flies of membrin RNAi flies were objected to 40° C for 120 seconds. Control flies do not show 
a seizing phenotype and no not show paralysis. Membrin RNAi flies do show twitches of the legs, wing 
flapping and loss of standing position (referred to as initial seizing).  When flies stopped their movement 
and were not in standing position, this is referred to as paralysis.  Paralysis of the flies was scored in a 
cumulative manner. Figure adapted from Parker et al. (Parker et al., 2011) 
(B-D) During the assay, flies were kept in transparent vials containing five to ten flies. Control flies did 
not show seizing behaviour (B) whereas Membrin downregulated flies do show an increasing 
accumulating number of flies that lose their standing position and are motionless (C, D).  
(E) 5 day old female Act-GAL4>UAS-membrin-RNAi or Act-GAL4>UAS-GFP (control) flies were tested for 
sensitivity to heat-induced seizures during exposure of 120 seconds in a 40 °C water bath. The numbers 
in brackets behind the genotype depict the overall number of flies tested. Vials, containing five-ten flies 
each, were scored in a cumulative manner at 5 second intervals for seizing flies. X and Y axis depict the 
% of control or RNAi treated flies seizing during exposure to heat. While the control flies never seized, 
the membrin-downregulated flies showed seizure-like behaviour in about 30% of the flies after 120 
seconds.  
 
Figure 3: Glial, but not neuronal knockdown of Drosophila membrin causes seizure-like behaviour in 
female and male flies 
(A-D) 3, 5 and 8 day old female (A/C) and 8 day old male (B/D) flies expressing UAS-membrin-RNAi under 
the control of neuronal drivers Elav-GAL4 and nSyb-GAL4, to downregulate membrin in neuronal cells, 
were treated as described in Figure 2. 8 day old flies expressing UAS-GFP under the control of the same 
drivers were used as controls. Seizure-like behaviour is absent in control flies as well as in flies in which 
membrin is downregulated in neuronal cells. 
(E-F) 3, 5 and 8 day old female (E) and male (F) flies expressing UAS-membrin-RNAi under the control of 
glial driver Repo-GAL4, to downregulate membrin in glia, were treated as in  Figure 2. 8 day old flies 
expressing UAS-GFP under the control of the same driver were used as controls. Compared to the 
controls flies, flies in which membrin is downregulated in glia, show an age-dependent increase in 
seizure-like behaviour. Of the females none seized at day 3, ~30% at day 5 and ~50% at day 8 (E). Males 
progressed slower, with a non-significant incidence (ns) of heat-induced seizures at both 3 and 5 days 
and ~30% of male flies seizing within 120 seconds at 8 days (F). 
Numbers in brackets depict the number of flies tested. Groups were compared using the Mantel-Cox 
log-rank-test. (*** p<0,001) 
 
Figure 4: Barbital suppresses seizure-like behaviour associated with glial loss of membrin 
(A-B) Repo-GAL4>UAS-membrin-RNAi flies and Repo-GAL4>UAS-GFP flies as controls (both females) 
were treated with barbital (0.5 mg/mL) added to the food of the adult flies during ageing (8 days) (A) or 
barbital was added only 24 hours before the ageing flies were exposure to heat (=barbital at day 7, heat 
exposure at day 8) (B). Either treatment suppressed the seizure-like behaviour of these flies. 
Number in brackets depicts the number of flies. Groups were compared using the Mantel-Cox log-rank 




Supplementary video 1 - Induction of seizure-like behaviour in glial membrin knockdown flies by heat 
shock (Repo>membrin RNAi females) 
Glial knockdown of membrin leads to prominent heat-induced seizure-like behaviour followed by 
paralysis in 8-day old female flies. A copper chamber heated to 40 °C was used to facilitate video 










Environmental factors Internal factors Medication/substance Situational factors Medication/substance 
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2 7 Male Gly144Trp Waking up Busy environment, 
lights, showering and 






3 7 Female Gly144Trp Waking up Heat, lights, noises, 








4 12 Male Gly144Trp Waking up Busy environment, 








5 17 Male Gly144Trp Before seizure, 
flanking sleep 
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Table 1 | Positive and negative (non-simultaneous) influences on NS-PME/PMA symptomatology as reported by patients 
  
10 31 Male Gly144Trp Oversleeping Busy environment, 








11 31 Male Gly144Trp Oversleeping Busy environment, 








12 35 Male 
 






























44 Female Gly144Trp Menses Busy environment, 
heat, lights, noises 









fever lying still 
Clonazepam 
 












1 4 Male  X  X 
2 7 Male X X  X 
3 7 Female X X X  
4 12 Male X    
5 17 Male X X X  
6 18 Female X X  X 
7 24 Male  X   
8 25 Male X X  X 
9 30 Male X X X  
10 31 Male X X X  
11 31 Male X X X  
12 35 Male X X X X 
13 40 Female     
14 44 Female X X X  
 
Table 2 | Distribution of reported heat-related factors negatively influencing NS-PME/PMA symptoms 
 (X) represent positive answers of (non-simultaneous) events. 
 
Factor Proportion of patients reporting exacerbation 
Fever 11/14 (79%) 
Any exogenous heat 12/14 (86%) 
Environmental heat 7/14 (50%) 
Shower/bath 5/14 (36%) 
Bright/flashing lights 12/14 (86%) 
Busy environment 11/14 (79%) 
Stress/anxiety 10/14 (71%) 
Noise 9/14 (64%) 
Illness 11/14 (79%) 
 
Table 3 | Incidence of factors negatively influencing NS-PME/PMA symptoms 
Lambrechts et al, Figure 1
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Fisher’s Exact Test P<0,0001
Females























































































































































































































































































































Knockdown: Act>membrin RNAi (97)
***
Females
Lambrechts et al., Figure 2






































Control: Elav>GFP 8d (89)
Knockdown: Elav>membrin RNAi 3d (12)
Knockdown: Elav>membrin RNAi 5d (29)
Knockdown: Elav>membrin RNAi 8d (78)








Control: nSyb>GFP 8d (69)
Knockdown: nSyb>membrin RNAi 3d (60)
Knockdown: nSyb>membrin RNAi 5d (58)
Knockdown: nSyb>membrin RNAi 8d (104)
E
Control: Repo>GFP 8d (77)
Knockdown: 
Repo>membrin RNAi 3d (59)
Knockdown: 
Repo>membrin RNAi 5d (127)
Knockdown: 
Repo>membrin RNAi 8d 
(106)






































Knockdown: nSyb>membrin 8d RNAi (85)








Control: nSyb>GFP 8d (58)
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50 Control: Repo>GFP 8d (35)
Knockdown: Repo>membrin RNAi 3d (100)
Knockdown: Repo>membrin RNAi 5d (100)



































8 days Barbital Treatment












+ Barbital (0.5 mg/ml) 
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24 hrs Barbital Treatment









Knockdown: Repo>membrin RNAi (122)
Knockdown: Repo>membrin RNAi
+ Barbital (0.5 mg/ml) (124)
Control: Repo>GFP + 
Barbital (0.5 mg/ml) (26)
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